Blog
RSS FeedPosted by Michael Wonder on 15 Jul 2019
China to soften generic drug buying program
15 July 2019 - Chinese drug makers jumped on Monday after a local news report that a centralised drug procurement ...
Posted by Michael Wonder on 08 Jul 2019
Priority review granted to BeiGene’s supplemental new drug application in China for tislelizumab in urothelial carcinoma
7 July 2019 - BeiGene today announced that the China National Medical Products Administration has granted priority review status to the ...
Posted by Michael Wonder on 04 Jun 2019
China’s revolutionary cancer drugs undercut American competitors
4 June 2019 - One way to realise Beijing’s dreams of a world-class pharmaceutical industry: low prices. ...
Posted by Michael Wonder on 03 Jun 2019
Chinese policies fail to curb soaring drug prices
2 June 2019 - Power of pharmaceutical monopoly starts with the manufacturing of ingredients. ...
Posted by Michael Wonder on 27 May 2019
Improving access to high cost technologies in the Asia region
24 May 2019 - Discussions at the Health Technology Assessment International Asia Policy Forum aimed to understand the meaning of ...
Posted by Michael Wonder on 25 Apr 2019
More affordable drugs offered with health care reform
25 April 2019 - China's health care reform has offered more affordable drugs for patients, said a senior health official ...
Posted by Michael Wonder on 07 Apr 2019
Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?
6 April 2019 - Nearly a quarter of the world’s newly diagnosed cancer cases in 2015 were in China. ...
Posted by Michael Wonder on 02 Apr 2019
Novartis first-in-class Cosentyx approved in China for psoriasis patients
2 April 2019 - China Health Authority NMPA approved Cosentyx (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are ...
Posted by Michael Wonder on 25 Mar 2019
VAT cut on ‘orphan drugs’ will lift healthcare burden, but many still struggle to afford medication
24 March 2019 - China has reduced value-added tax (VAT) by 3% on 21 orphan drugs and four active pharmaceutical ingredients ...
Posted by Michael Wonder on 25 Mar 2019
China pledges stronger reform on approving, monitoring new drugs
23 March 2019 - China pledged to improve its system for registering new drugs in the country this year and ...
Posted by Michael Wonder on 23 Mar 2019
A tiered health care delivery system for China
22 March 2019 - “China's health-care reform will be regarded as successful when a tiered health-care delivery system is fully ...
Posted by Michael Wonder on 19 Mar 2019
Think drugs are expensive in the U.S.? Just try China
19 March 2019 - Beijing will want pharma companies to share the pain of the country’s growing health care costs. ...
Posted by Michael Wonder on 06 Mar 2019
China moves to expand cancer medicine access
6 March 2019 - China's recent policy to increase patients' access to cancer medicines has helped more people receive quality ...
Posted by Michael Wonder on 27 Feb 2019
China approves first biosimilar of foreign drug, breaking Roche monopoly
27 February 2019 - China’s National Medical Products Administration announced Monday that it has approved the country's first biosimilar drug ...
Posted by Michael Wonder on 19 Feb 2019
China to establish collaboration network for rare disease diagnosis, treatment
18 February 2019 - China will establish a national collaborative network of hospitals for rare disease diagnosis and treatment to ...